Costs comparison of treating diabetic macular edema with aflibercept, ranibizumab or dexamethasone at 1 year in France (INVICOST study):

Pierre Gascon,Isabelle Borget,Alban Comet,Laurence Carton,Frédéric Matonti,Laure Dupont-Benjamin

Costs comparison of treating diabetic macular edema with aflibercept, ranibizumab or dexamethasone at 1 year in France (INVICOST study):

2021

Pierre Gascon
Isabelle Borget
Alban Comet
Laurence Carton
Frédéric Matonti
Laure Dupont-Benjamin

Purpose:INVICOST, a medico-economic analysis, compared costs of managing treatment-naive patients with diabetic macular edema (DME) receiving intravitreal injections (IVIs) of aflibercept (AFL), de...

Keywords:

Dexamethasone
Ophthalmology
Ranibizumab
Dexamethasone Intravitreal Implant
Macular edema
diabetic macular edema
Aflibercept
Cost-minimization analysis
Diabetic retinopathy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations